<DOC>
	<DOCNO>NCT01257958</DOCNO>
	<brief_summary>Phase 1 study 19-nor Vitamin D relapsing-remitting MS. Primary measure MRI .</brief_summary>
	<brief_title>Vitamin D Pilot Study Patients With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>relapse remit MS MRI contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Vitamin D , 19 Vitamin D , Multiple Sclerosis</keyword>
</DOC>